Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin Priming in Pancreatic Fine Needle Biopsy
NCT04764396Terminated
- Sponsor
- University of Michigan
- Start
- Mar 2021
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial comparing Heparin priming biopsies with Standard of care (saline) (2 arms). Primary endpoints: Cellularity Captured in Fine Needle Biopsies at Day 1 and Blood Contamination in Fine Needle Biopsies at Day 1. Started Mar 2021; status: terminated.
02
Drugs
heparin
Beyond the preview
Go deeper on NCT04764396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764396.